Identification and Antifungal Susceptibility Pattern of Candida Isolates Recovered from Urine and Blood Specimens from Patients Admitted in Wards of a Tertiary Care Hospital, North Delhi

Authors

  • Sanjay Jain Head of Department, Microbiology, NDMC Medical College and HRH, Delhi
  • Shilpa Khatri Senior Resident, Microbiology, NDMC Medical College and HRH, Delhi
  • Manoj Kumar Associate Professor, Microbiology, NDMC Medical College and HRH, Delhi
  • Tanisha Bharara Assistant Professor, Microbiology, NDMC Medical College and HRH, Delhi
  • Abhishek Yadav Assistant Professor, Microbiology, NDMC Medical College and HRH, Delhi

DOI:

https://doi.org/10.26911/jepublichealth.2024.09.02.08

Abstract

Background: Candida species are responsible for various clinical infections ranging from mucocutaneous infection to life-threatening invasive diseases. Increased resistance to antifungal drugs during the last decade has become a serious concern. Therefore, identification of Candida up to species level and its antifungal susceptibility testing is very important in the management of Candida infections. This study aimed to identify these organisms and study their susceptibility patterns.
Subjects and Method: A retrospective study was conducted over 9 months (July 2022 to March 2023) from urine and blood samples collected from 80 IPD patients admitted to various wards of Hindu Rao Hospital. The samples were selected based on their growth on blood agar. The variables of interest are the different species of Candida and susceptibility to antibiotics. Identification of Candida species was done by Gram stain, Germ tube formation test, color on HiCrome Candida agar medium, chlamydospore formation on corn meal agar, and VITEK 2 Compact System. The MICs were interpreted according to the CLSI guidelines 2022.
Results: 47 and 33 of urine and blood cultures were positive for Candida species respectively. Most of the isolates were from the Paediatric ward (28.75%), followed by the Medicine ward (27.5%). The most common species was C. tropicalis (56.25%) followed by C. albicans (23.75%). Most species of Candida were sensitive to amphotericin B, fluconazole, voriconazole, caspofungin, micafungin, and flucytosine except Candida albicans which showed 100% resistance to amphotericin B and Candida krusei which showed 66% sensitivity to voriconazole and 33% to caspofungin.
Conclusion: Candida colonization has a considerable prevalence among patients hospitalized in our hospital. The species identification of Candida isolates along with their antifungal susceptibility pattern can help the clinician in better treatment of patients with candiduria and candidemia.

Keywords: Candida, bloodstream infection, minimum inhibitory concentration

Author Biographies

Shilpa Khatri, Senior Resident, Microbiology, NDMC Medical College and HRH, Delhi

Head of Department, Microbiology, NDMC Medical College & HRH, Delhi

Manoj Kumar, Associate Professor, Microbiology, NDMC Medical College and HRH, Delhi

Senior Resident, Microbiology, NDMC Medical College & HRH, Delhi

Tanisha Bharara, Assistant Professor, Microbiology, NDMC Medical College and HRH, Delhi

Assistant Professor, Microbiology, NDMC Medical College & HRH, Delhi

Abhishek Yadav, Assistant Professor, Microbiology, NDMC Medical College and HRH, Delhi

Assistant Professor, Microbiology, NDMC Medical College & HRH, Delhi

References

Ahmed S, Shahid M, Fatima N, Khan F, Tayyaba U (2020). Candidemia – Changing trends from Candida albicans to Non-albicans Candida from a tertiary care center in western UP, India. CHRISMED J Health Res.; 7(3): 167-172. doi: 10.4103/cjhr.cjhr_12_20

Aijaz N, Kaur K (2023). Speciation and anti-fungal susceptibility pattern of Candida isolated from blood and body fluids. Indian J Microbiol Res. 10(1): 18-21.

Amar CS, Ashish J, Hajare V, Shreekantha, Yogesh B, Vinodchandran (2013). Study of prevalence and antifungal susceptibility of Candida. Int J Pharm Bio Sci. 4(2): 361- 381.

Bukhary ZA (2008). Candiduria: a review of clinical significance and management. Saudi J Kidney Dis Transpl. 19(3): 350–360.

Chenoweth CE, Gould CV, Saint S (2014). Diagnosis, management, and prevention of catheter-associated urinary tract infections. Infect Dis Clin North Am. 28(1): 105–119.

CLSI (2022). Performance Standards for Antifungal Susceptibility Testing of Yeasts 3rd ed. CLSI supplement M27M44S. Clinical and Laboratory Standards Institute.

Colombo AL, Garnica M, Aranha-Camargo LF, Cunha CA, Bandeira AC, Borghi D, Campos T, et al. (2013). Candida glabrata: an emerging pathogen in Brazilian tertiary care hospitals. Med Mycol. 51(1): 38–44.

Colombo AL, Guimarães T (2007). Candi-dúria: uma abordagem clínica e tera-pêutica. Rev Soc Bras Med Trop. 40(3): 332-337.

Das M, Sharma A, Loomba PS, Mishra B (2022). Speciation, risk factors, and antifungal susceptibility pattern of Candida isolates from urine sample of ICU patients: An observational cross-sectional study. J Health Res Rev. 9: 3-9.

Desai DJ, Gilbert B, McBride CA (2016). Pediatric urinary tract infections: Diagnosis and treatment. Aust Fam Physician. 45(8): 558-563.

Fisher JF, Kavanagh K, Sobel JD, Kauffman CA, Newman CA (2011). Candida urinary tract infection: pathogenesis. Clin Infect Dis. 52(6): S437–S451.

Gudlaugsson O, Gillespie S, Lee K, Berg VJ, Hu J, Messer S, Herwaldt L, et al. (2003). Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis. 37(9): 1172- 1177.

Huang PY, Hung MH, Shie SS, Su LH, Chen KY, Ye JJ, Chiang PC, et al. (2013). Molecular concordance of concurrent Candida albicans candidemia and candiduria. Diagn Microbiol Infect Dis. 76: 382-384.

Jain M, Dogra V, Mishra B, Thakur A, Loomba PS, Bhargava A (2011). Candi-duria in catheterized intensive care unit patients: emerging microbiological trends. Indian J Pathol Microbiol. 54(3): 552–555. doi: 10.4103/0377-4-929.85091

Kandhari KC, Rama-Rao KM (1969). Clinical and laboratory studies on cutaneous Candidiasis. Indian J Dermatol Venereol. 35(3): 102-107.

Kauffman CA (2014). Diagnosis and management of fungal urinary tract infection. Infect Dis Clin North Am. 28(1): 61-74.

Kauffman CA (2005). Candiduria. Clin Infect Dis. 41(6): S371–S376. doi: 10.1086/430918.

Kobayashi CC, Fernandes OF, Miranda KC, Sousa ED, Silva MR (2004). Candiduria in hospital patients: a study prospective. Mycopathologia. 158: 49–52.

Mehta R, Wyawahare AS (2016). Evaluation of Hicrome Candida differential agar for species identification of Candida isolates from various clinical samples. Int J Cont Med Res. 3(4): 1219-1222.

Mishra NN, Ali S, Shukla PK (2014). Arachidonic acid affects biofilm formation and PGE2 level in Candida albicans and non-albicans species in presence of subinhibitory concentration of fluconazole and terbinafine. Braz J Infect Dis. 18: 287–293.

Pahwa N, Kumar R, Nirkhiwale S, Bandi A (2014). Species distribution and drug susceptibility of candida in clinical isolates from a tertiary care centre at Indore. Indian J Med Microbiol. 32(1): 44-48.

Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, Edwards JE Jr, Filler SG, et al. (2009). Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 48(1): 503-535.

Pfaller MA, Castanheira M (2016). Noso-comial candidiasis: antifungal steward-ship and the importance of rapid diagnosis. Med Mycol. 54(1): 1–22.

Saha R, Dasm S, Kumar A, Kaur IR (2008). Pattern of Candida isolates in hospitalized children. Indian J Pediatr. 75: 858-860.

Sandhu R, Dahiya S, Sharma RK (2016). Isolation and identification of Candida and Non albicans Candida species using chromogenic medium. Int J Biomed Res. 6(12): 958-962.

Seifi Z, Azish M, Salehi Z, Zarei Mahmou-dabadi A, Shamsizadeh A (2013). Candiduria in children and susceptibility patterns of recovered Candida species to antifungal drugs in Ahvaz. J Nephropathol. 2(2): 122–128. doi: 10.12860/JNP.2013.20.

Shaik N, Penmetcha U, Myneni RB, Yarla-gadda P, Singamsetty S (2016). A study of identification and antifungal susceptibility pattern of Candida species isolated from various clinical specimens in a tertiary care teaching hospital, Chinakakani, Guntur, Andhra Pradesh, South India. Int J Curr Microbiol App Sci. 5(7): 71-91.

Shaikh N, Hoberman A (2017). Urinary tract infections in infants and children older than one month: clinical features and diagnosis. Available at www.upto-date.com. Updated October 5, 2017.

Singla N, Gulati N, Kaistha N, Chander J (2012). Candida colonization in urine samples of ICU patients: determination of etiology, antifungal susceptibility testing, and evaluation of associated risk factors. Mycopathologia. 174: 149–155.

Sobel JD, Fisher JF, Kauffman CA, Newman CA (2011). Candida urinary tract infections - Epidemiology. Clin Infect Dis. 52(6): S433–S436.

Sulaiman SP, Singh R, Mandal J (2014). Fungal profile of funguria cases at a tertiary care hospital in southern

India. Indian J Med Res. 140(4).

Tortorano AM, Biraghi E, Astolfi A, Ossi C, Tejada M, Farina C, et al. (2002). European Confederation of Medical Mycology (ECMM) prospective survey of candidaemia: report from one Italian region. J Hosp Infect. 51(4): 297-304.

Yashavanth R, Shiju MP, Bhaskar UA, Ronald R, Anita KB (2013). Candi-duria: prevalence and trends in anti-fungal susceptibility in a tertiary care hospital of Mangalore. J Clin Diagn Res. 7(11): 2459–2461.

Zarei-Mahmoudabadi A, Zarrin M, Ghanatir F, Vazirianzadeh B (2012). Candiduria in hospitalized patients in teaching hospitals of Ahvaz. Iran J Microbiol. 4(4): 198–203.

Downloads

Published

2024-04-16

How to Cite

Jain, S., Khatri, S., Kumar, M., Bharara, T., & Yadav, A. (2024). Identification and Antifungal Susceptibility Pattern of Candida Isolates Recovered from Urine and Blood Specimens from Patients Admitted in Wards of a Tertiary Care Hospital, North Delhi. Journal of Epidemiology and Public Health, 9(2), 216–226. https://doi.org/10.26911/jepublichealth.2024.09.02.08

Issue

Section

Articles